-
Je něco špatně v tomto záznamu ?
Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study
FA. da Costa, K. Mala-Ladova, V. Lee, S. Tous, J. Papastergiou, D. Griffiths, MC. Chaumais, KE. Hersberger, R. Viola, E. Paulino, T. Lobban, L. Neubeck, B. Freedman, S. Antoniou
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, multicentrická studie
NLK
ProQuest Central
od 1998-06-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2011-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1998-06-01 do Před 1 rokem
- MeSH
- časná diagnóza MeSH
- dospělí MeSH
- farmaceuti * MeSH
- fibrilace síní diagnóza MeSH
- internacionalita MeSH
- lidé středního věku MeSH
- lidé MeSH
- průřezové studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- zdraví - znalosti, postoje, praxe MeSH
- zdravotní výchova metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
Atrial fibrillation (AF) accounts for up to one third of strokes, one of the lead mortality causes worldwide. The European Society of Cardiology guidelines recommend opportunistic screening as a means to increase the odds of early detection and institution of appropriate treatment according to risk factors identified. However, in most countries there are various barriers to effective uptake of screening, including low awareness. The Atrial Fibrillation Association is a patient association engaged with raising awareness of AF. Establishing a partnership with the International Pharmacists for Anticoagulation Care Taskforce, we set as goals to test a model for raising awareness of AF involving pharmacists globally; and to identify barriers and enablers to its implementation. A cross-sectional study was conducted during the Arrhythmia Alliance World Heart Rhythm Week. Pharmacists from 10 countries invited individuals (≥ 40 years; without anticoagulation therapy of AF) to participate in the awareness campaign. Participants agreeing were engaged in the early detection of AF (EDAF) using pulse palpation. Individuals with rhythm discrepancies were referred and prospectively assessed to have information on the proportion of confirmed diagnosis, leading to estimate the detection rate. Interviews with country coordinators explored barriers and enablers to implementation. The study involved 4193 participants in the awareness campaign and 2762 in the EDAF event (mean age 65.3 ± 13.0), of whom 46.2% individuals were asymptomatic, recruited across 120 sites. Most common CHA2DS2-VASc risk factor was hypertension. Among 161 patients referred to physician, feedback was obtained for 32 cases, of whom 12 new arrhythmia diagnoses were confirmed (5 for AF, 2 for atrial flutter), all among elders (≥ 65 years). Qualitative evaluation suggested a local champion to enable pharmacists' success; technology enhanced engagement amongst patients and increased pharmacists' confidence in referring to physicians; interprofessional relationship was crucial in success. This study suggests pharmacists can contribute to greater outreach of awareness campaigns. Effective communication pathways for inter-professional collaboration were suggested enablers to gain full benefits of EDAF.
Barts Health NHS Trust UCL Partners 9 Prescot Street Aldgate London E1 8PR UK
Centre for Learning Enhancement and Research The Chinese University of Hong Kong Shatin Hong Kong
Faculdade de Farmácia The Research Institute for Medicines Universidade de Lisboa Lisbon Portugal
Faculty of Pharmacy University of Szeged Zrínyi u 9 Szeged 6720 Hungary
Farmácia Nuno Álvares Avenida D Nuno Álvares Pereira 39 C Almada Portugal
Leslie Dan Faculty of Pharmacy University of Toronto 144 College St Toronto ON M5S 3M2 Canada
Westview Pharmacy 5 Glendale Road Glen Eden Auckland 0602 New Zealand
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012650
- 003
- CZ-PrNML
- 005
- 20210507103351.0
- 007
- ta
- 008
- 210420s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11239-019-02000-x $2 doi
- 035 __
- $a (PubMed)31782043
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a da Costa, Filipa Alves $u Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Campus Universitário, Quinta da Granja, Monte da Caparica, 2829-511, Caparica, Portugal. alvesdacosta.f@gmail.com $u Faculdade de Farmácia, The Research Institute for Medicines (iMED.ULisboa), Universidade de Lisboa, Lisbon, Portugal. alvesdacosta.f@gmail.com
- 245 10
- $a Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study / $c FA. da Costa, K. Mala-Ladova, V. Lee, S. Tous, J. Papastergiou, D. Griffiths, MC. Chaumais, KE. Hersberger, R. Viola, E. Paulino, T. Lobban, L. Neubeck, B. Freedman, S. Antoniou
- 520 9_
- $a Atrial fibrillation (AF) accounts for up to one third of strokes, one of the lead mortality causes worldwide. The European Society of Cardiology guidelines recommend opportunistic screening as a means to increase the odds of early detection and institution of appropriate treatment according to risk factors identified. However, in most countries there are various barriers to effective uptake of screening, including low awareness. The Atrial Fibrillation Association is a patient association engaged with raising awareness of AF. Establishing a partnership with the International Pharmacists for Anticoagulation Care Taskforce, we set as goals to test a model for raising awareness of AF involving pharmacists globally; and to identify barriers and enablers to its implementation. A cross-sectional study was conducted during the Arrhythmia Alliance World Heart Rhythm Week. Pharmacists from 10 countries invited individuals (≥ 40 years; without anticoagulation therapy of AF) to participate in the awareness campaign. Participants agreeing were engaged in the early detection of AF (EDAF) using pulse palpation. Individuals with rhythm discrepancies were referred and prospectively assessed to have information on the proportion of confirmed diagnosis, leading to estimate the detection rate. Interviews with country coordinators explored barriers and enablers to implementation. The study involved 4193 participants in the awareness campaign and 2762 in the EDAF event (mean age 65.3 ± 13.0), of whom 46.2% individuals were asymptomatic, recruited across 120 sites. Most common CHA2DS2-VASc risk factor was hypertension. Among 161 patients referred to physician, feedback was obtained for 32 cases, of whom 12 new arrhythmia diagnoses were confirmed (5 for AF, 2 for atrial flutter), all among elders (≥ 65 years). Qualitative evaluation suggested a local champion to enable pharmacists' success; technology enhanced engagement amongst patients and increased pharmacists' confidence in referring to physicians; interprofessional relationship was crucial in success. This study suggests pharmacists can contribute to greater outreach of awareness campaigns. Effective communication pathways for inter-professional collaboration were suggested enablers to gain full benefits of EDAF.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a fibrilace síní $x diagnóza $7 D001281
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a časná diagnóza $7 D042241
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zdravotní výchova $x metody $7 D006266
- 650 _2
- $a zdraví - znalosti, postoje, praxe $7 D007722
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a internacionalita $7 D038622
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a farmaceuti $7 D010595
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Mala-Ladova, Katerina $u Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovského, 1203/8, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Lee, Vivian $u Centre for Learning Enhancement and Research, The Chinese University of Hong Kong, Shatin, Hong Kong
- 700 1_
- $a Tous, Salvador $u Sociedad Española de Farmacia Familiar y Comunitaria SEFAC, Travessera de Gràcia, 56, 08006, Barcelona, Spain
- 700 1_
- $a Papastergiou, John $u Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St, Toronto, ON, M5S 3M2, Canada
- 700 1_
- $a Griffiths, Dale $u Westview Pharmacy, 5 Glendale Road, Glen Eden, Auckland, 0602, New Zealand
- 700 1_
- $a Chaumais, Marie-Camille $u Faculté de Pharmacie, Hôpital Antoine Béclère, Université Paris-Sud, 157, Rue de la Porte de Trivaux, 92140, Clamart, France
- 700 1_
- $a Hersberger, Kurt E $u Pharmaceutical Care Research Group, University of Basel, Pharmazentrum, Klingelbergstrasse 50, 4056, Basel, Switzerland
- 700 1_
- $a Viola, Reka $u Faculty of Pharmacy, University of Szeged, Zrínyi u. 9, Szeged, 6720, Hungary
- 700 1_
- $a Paulino, Ema $u Farmácia Nuno Álvares, Avenida D. Nuno Álvares Pereira, 39-C, Almada, Portugal
- 700 1_
- $a Lobban, Trudie $u Atrial Fibrillation Association (AF Assoc)/ Arrhythmia Alliance (A-A), AF Association, Unit 6B, Essex House, Cromwell Business Park, Chipping Norton, Oxfordshire, OX7 5SR, UK
- 700 1_
- $a Neubeck, Lis $u School of Health and Social Care, Edinburgh Napier University, Sighthil Campus, Sighthill Court, Edinburgh, EH11 4BN, Scotland, UK
- 700 1_
- $a Freedman, Ben $u Heart Research Institute, Charles Perkins Centre, University of Sydney, John Hopkins Dr, Camperdown NSW, Sydney, 2006, Australia
- 700 1_
- $a Antoniou, Sotiris $u Barts Health NHS Trust, UCL Partners, 9 Prescot Street Aldgate, London, E1 8PR, UK
- 773 0_
- $w MED00007760 $t Journal of thrombosis and thrombolysis $x 1573-742X $g Roč. 49, č. 4 (2020), s. 606-617
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31782043 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210507103350 $b ABA008
- 999 __
- $a ok $b bmc $g 1650920 $s 1133029
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 49 $c 4 $d 606-617 $e - $i 1573-742X $m Journal of thrombosis and thrombolysis $n J Thromb Thrombolysis $x MED00007760
- LZP __
- $a Pubmed-20210420